Dynamic Purchasing System for Pharmaceutical Products
Oryginalny tytuł ogłoszenia
Italy-Naples: Pharmaceutical products
Ocena szansy
Skąd ta ocena?
Szansa
60 / 100
Złożoność
45 / 100
Czynniki ryzyka
The estimated value of 20 billion EUR appears extremely high and may be a data entry error. This could misrepresent the...
Key details such as specific product categories, sub-lots, qualification requirements, and detailed award criteria are...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Najważniejsze informacje
- Zamawiający
- SOCIETA' REGIONALE PER LA SANITA' (SO.RE.SA. S.P.A.)
- Kraj
- Włochy
- CPV
- 33600000 - Pharmaceutical products
- Termin
- Aug 01, 2029
- Szacowana wartość
- EUR 20000M
Przegląd
Moderate opportunityKluczowe fakty
- EUR 20000M estimated value
- Supplies contract
- 1 lot
- Supply of pharmaceutical products including drugs, blood-derived products, vaccines, etc.
- The DPS is open to healthcare authorities in the Campania region and possibly other Italian regions.
Pokaż pełne podsumowanie
This notice announces the establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products (drugs, blood-derived products, vaccines, etc.) to healthcare authorities in the Campania region, Italy. The DPS has a total estimated value of 20 billion EUR and a duration of 72 months. The procedure is restricted and the award criterion is the most economically advantageous tender. Submission is open until 2029-08-01 12:00, and all communication is in Italian.
Ryzyka
The estimated value of 20 billion EUR appears extremely high and may be a data entry error. This could misrepresent the...
Key details such as specific product categories, sub-lots, qualification requirements, and detailed award criteria are...
Restricted procedure — pre-qualification required
No procurement documents available
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- Registration in the Chamber of Commerce register for activities related to the object of the DPS.
Administrative
- Tenders must be submitted in Italian.
- Submission for all lots (single lot).
Zamawiający
Lokalizacja
Naples, ITA
Strona
Profil zamawiającego
Identyfikator
7691971
Działalność
General public services
Części (1)
Lot 1
Dynamic Purchasing System for Pharmaceutical Products
Establishment of a DPS for the supply of pharmaceutical products (drugs, blood-derived products, vaccines, etc.) to healthcare authorities in Campania region and possibly other Italian regions.
EUR 20B
Szacowana wartość
Kategoria
Termin
Uwaga do wartości
Szczegóły zamówienia
- Data publikacji
- 06 Aug 2023
- Języki
- Italian
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 479081-2023
Podobne przetargi
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Ocena szansy
Skąd ta ocena?
Szansa
60 / 100
Złożoność
45 / 100
Czynniki ryzyka
The estimated value of 20 billion EUR appears extremely high and may be a data entry error. This could misrepresent the...
Key details such as specific product categories, sub-lots, qualification requirements, and detailed award criteria are...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications